C 9 D

10XDNA Disruptive Technologies R

Mutual Fund
Mutual Fund
ISIN: DE000DNA10X3
Ticker: C9D4
DE000DNA10X3
C9D4

Price

Price

CHART BY

Data

TER

 
1.94%

Fund Volume

 
$60.91M

Asset Class

 
Equity

Distributing

 
Yes

Region

 
Global

Country Based

 
Germany

Issuer

 
Axxion

Historical dividends and forecast

All dividend data

 The next dividend will be paid on 19.12.2025


$0.26

CHART BY

Industry Breakdown

  • Packaged Software
    17.34%
  • Semiconductors
    15.93%
  • Finance/ Rental/ Leasing
    6.88%
  • Internet Retail
    6.63%
  • Investment Trusts/ Mutual Funds
    6.49%
  • Biotechnology
    5.18%
  • Other Consumer Services
    4.56%
  • Air Freight/ Couriers
    4.29%
  • Trucks/ Construction/ Farm Machinery
    3.38%
  • Electrical Products
    3.38%
  • Regional Banks
    3.37%
  • Medical Distributors
    3.28%
  • Property/ Casualty Insurance
    3.07%
  • Electronic Production Equipment
    2.88%

Sector Breakdown

  • Information Technology
    24.61%
  • Financials
    17.12%
  • Industrials
    12.7%
  • Consumer Staples
    9.91%
  • Health Care
    9.38%
  • Consumer services
    9.2%
  • Non corporate
    6.49%
  • Consumer Discretionary
    5.59%
  • Other
    2.78%
  • Business services
    2.22%

Region Breakdown

  • 🇺🇸

    USA
    31.03%
  • 🇨🇳

    China
    15.78%
  • 🇸🇬

    Singapore
    8.85%
  • 🇨🇭

    Switzerland
    5.6%
  • 🇰🇿

    Kazakhstan
    5.1%
  • 🇩🇰

    Denmark
    3.38%
  • 🇰🇾

    Cayman Islands
    3.37%
  • 🇹🇼

    Taiwan, Province of China
    3.36%
  • 🇱🇺

    Luxembourg
    3.35%
  • 🇳🇱

    Netherlands
    3.28%
  • 🇩🇪

    Germany
    3.24%
  • 🏳️

    Other
    2.8%
  • 🇺🇾

    Uruguay
    2.63%
  • 🇮🇱

    Israel
    2.62%

Pricing

1D span
$25.53$25.83
52W span
$16.97$26.33

Information

The aim of the investment policy is to generate capital growth. - The UCITS invests without focusing on a specific region

Identifier

ISIN
DE000DNA10X3
Primary Ticker
C9D4

Knockouts

Real-time data from LSX · Fundamentals & EOD data from FactSet
Join the conversation